Published in Cancer Weekly, February 12th, 2008
"Finally, consistent handling of dose calculation deviations applying individual action levels is discussed. A Matlab-based software ('MUV') was distributed to five well-established treatment centres in Europe (Vienna, Graz, Basel, Copenhagen, and Umeň) and evaluated as...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.